“IMMUNE CHECKPOINT INHIBITOR SALVAGE THERAPY IN PATIENT WITH REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA” (2019) Voprosy onkologii, 65(2), pp. 294–297. doi:10.37469/0507-3758-2019-65-2-294-297.